HIDA Government Affairs Alert

August 29, 2018

Reminder: Action Needed on Proposed US Tariffs

HIDA Government Affairs still needs your help weighing in with the office of the United States Trade Representative (USTR) – your voice is crucial on this issue. At issue are the proposed 25% tariffs and the drastic impact they will have on the healthcare supply chain and the patients we serve.

In July, the USTR issued a Notice of Determination and Request for Public Comment regarding proposed tariffs on thousands of Chinese-manufactured products. Like the previous two lists, this proposed tariff list includes medical products. If enacted, a 25% tariff would be applied to countless healthcare products, including gloves, isolation gowns, specimen bags, and wet wipes.

HIDA President & CEO Matthew J. Rowan testified last week before the USTR, outlining industry concerns with the most recent proposal to place tariffs on a number of critical medical products. Rowan advanced HIDA's position that all healthcare products should be exempt from any additional tariffs. His testimony detailed how the proposed tariffs will increase the cost of healthcare for all Americans and hinder our country’s ability to respond to public health emergencies.

It is urgent that you take action no later than Thursday, September 6th and submit comments addressing the industry’s concerns with the proposed tariffs.

Submit Your Comments To USTR»

Read HIDA’S Official Testimony»

See List Of Healthcare Products On The List»

Please contact HIDA Government Affairs with any questions, comments or concerns at HIDAGovAffairs@HIDA.org or at 703-549-4432.

HIDA Government Affairs appreciates the support of its membership, and your participation makes a difference.